Tham khảo Triamterene

  1. ↑ LoSalt Advisory Statement (PDF) Error in webarchive template: Check |url= value. Empty.
  2. ↑ Pubmed: "Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects.", Ann Intern Med. 1982 Mar;96(3):317-20.
  3. ↑ Busch AE; Suessbrich H; Kunzelmann K và đồng nghiệp (tháng 9 năm 1996). “Blockade of epithelial Na+ channels by triamterenes - underlying mechanisms and molecular basis”. Pflügers Arch. 432 (5): 760–6. PMID 8772124. doi:10.1007/s004240050196. 
  4. 1 2 3 Fink, Cynthia A; McKenna, Jeffrey M.; Werner, Lincoln H. (2003). “Diuretic and Uricosuric Agents”. Trong Abraham, Donald J. Burger's medicinal chemistry and drug discovery. Volume 3: Cardiovascular Agents and Endocrines (ấn bản 6). Wiley. tr. 55–154. ISBN 978-0471370291. 
  5. ↑ "Triamterene and Hydrochlorothiazide". MedlinePlus. U.S. National Library of Medicine. National Institutes of Health. September 1, 2008.
  6. ↑ Crosley AP và đồng nghiệp (1962). “Triamterene, A New Natruretic Agent: Preliminary Observations in Man”. Ann Intern Med 56 (2): 241–251. PMID 13882367. doi:10.7326/0003-4819-56-2-241. 
  7. ↑ Heath WC, Freis ED (tháng 10 năm 1963). “Triamterene with Hydrochlorothiazide in the Treatment of Hypertension”. JAMA 186 (2): 119–22. PMID 14056525. doi:10.1001/jama.1963.03710020039012. 
  8. ↑ Ralph Landau, Basil Achilladelis, Alexander Scriabine. Pharmaceutical Innovation: Revolutionizing Human Health. Volume 2 of Chemical Heritage Foundation series in innovation and entrepreneurship. Chemical Heritage Foundation, 1999 ISBN 9780941901215
  9. ↑ FDA Approval History NDA 016042: Dyazide. Page accessed Sept 8 2016
  10. 1 2 3 Ron Wolf for The Philadelphia Inquirer. August 22, 1987 Smithkline Loses Exclusive Rights To Drug
  11. ↑ Boehm, Garth; Yao, Lixin; Han, Liang; Zheng, Qiang (tháng 9 năm 2013). “Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984”. Acta Pharmaceutica Sinica B 3 (5): 297–311. doi:10.1016/j.apsb.2013.07.004. 
  12. 1 2 John Seaman and John T. Landry. Mylan 50 Years of Unconventional Success. Mylan, in association with University Press of New England, 2011. ISBN 9781611682700. Page 50
  13. ↑ Strickland, Carol (15 tháng 10 năm 1989). “Bolar: A Drug Company Under Siege”. The New York Times. 
  14. ↑ Cimons, Marlene (29 tháng 8 năm 1989). “FDA to Lift OK of Last Dyazide Generic Version”. Los Angeles Times. 
  15. ↑ “Bolar Recalls Generic Version Of Dyazide And Extended Release Phenytoin, Saying "Bioequivalence Cannot Be Assured"; Products; Represent 52% of Sales”. Pink Sheet. 5 tháng 2 năm 1990. 
  16. ↑ Shaw, Donna (27 tháng 2 năm 1991). “U.s. Charges Bolar Pharmaceutical With Misrepresenting Its Products”. The Philadelphia Inquirer. 
  17. ↑ Freudenheim, Milt (28 tháng 2 năm 1991). “Bolar Plans Guilty Plea On Generics”. The New York Times. 
  18. 1 2 Freudenheim, Milt (10 tháng 9 năm 1989). “Exposing the F.D.A.”. The New York Times. 
  19. ↑ FDA Approval History NDA 019129: Maxzide Page accessed Sept 8, 2016
  20. 1 2 Pink Sheet Oct 22, 1984 Mylan's Maxzide is "Approvable" at FDA: Lederle To Market Brand Competition to Smithkline's No. 3-Ranked Dyazide; Final Approval Anticipated "Imminently"
  21. ↑ Reid, Kenneth (17 tháng 11 năm 1987). “US Judge to Rule on Drug Marketing”. Journal of Commerce. 
  22. ↑ Andrews, Edmund L. (31 tháng 7 năm 1989). “F.D.A. Inquiry on Generic Drugs Focuses on Changes in Ingredients”. The New York Times. 
  23. ↑ Drugs.com Generic Maxzide Page accessed Sept 8 2016
  24. ↑ Swartz R; Longwell P (tháng 3 năm 2005). “Treatment of vertigo” (PDF). Am Fam Physician 71 (6): 1115–22. PMID 15791890. 
  25. ↑ Sloane PD; Coeytaux RR; Beck RS; Dallara J (tháng 5 năm 2001). “Dizziness: state of the science”. Ann. Intern. Med. 134 (9 Pt 2): 823–32. PMID 11346317. doi:10.7326/0003-4819-134-9_Part_2-200105011-00005. 

Tài liệu tham khảo

WikiPedia: Triamterene http://www.chemspider.com/Chemical-Structure.5345.... http://www.drugs.com/monograph/triamterene.html http://www.joc.com/us-judge-rule-drug-marketing_19... http://articles.latimes.com/1989-08-29/news/mn-118... http://www.losalt.com/docs/lo_salt_web_advice.pdf http://articles.philly.com/1987-08-22/news/2617013... http://articles.philly.com/1991-02-27/business/257... http://www.accessdata.fda.gov/scripts/cder/drugsat... http://www.accessdata.fda.gov/scripts/cder/drugsat... //www.ncbi.nlm.nih.gov/pubmed/11346317